tiprankstipranks
Agilent (IT:1A)
:1A
Italy Market
1A
Agilent
RESEARCH TOOLSreports

Agilent (1A) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

1A Analyst Ratings

Strong Buy
16Ratings
Strong Buy
13 Buy
3 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Agilent
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1A Stock 12 Month Forecast

Average Price Target

€147.37
▲(19.52% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is €147.37 with a high forecast of €163.09 and a low forecast of €115.88. The average price target represents a 19.52% change from the last price of €123.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"95":"€95","164":"€164","112.25":"€112.3","129.5":"€129.5","146.75":"€146.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":163.0884494,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€163.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":147.36972713875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€147.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":115.8786351,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€115.88</span>\n  </div></div>","useHTML":true}}],"tickPositions":[95,112.25,129.5,146.75,164],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,118.4,121.83757303076924,125.27514606153846,128.7127190923077,132.15029212307692,135.58786515384617,139.02543818461538,142.46301121538463,145.90058424615384,149.33815727692308,152.7757303076923,156.21330333846154,159.6508763692308,{"y":163.0884494,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,118.4,120.62844054913462,122.85688109826924,125.08532164740384,127.31376219653846,129.54220274567308,131.77064329480768,133.99908384394232,136.22752439307692,138.45596494221155,140.68440549134615,142.91284604048076,145.1412865896154,{"y":147.36972713875,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,118.4,118.20604885384616,118.0120977076923,117.81814656153847,117.62419541538462,117.43024426923077,117.23629312307692,117.04234197692308,116.84839083076923,116.65443968461538,116.46048853846153,116.2665373923077,116.07258624615385,{"y":115.8786351,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":96.864,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.802,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.457,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.299,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":129.175,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.015,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.548,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.657,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.904,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.277,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.682,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.3,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€163.09Average Price Target€147.37Lowest Price Target€115.88
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on IT:1A
Evan Stampler
Wells Fargo
Wells Fargo
€137.34→€154.5
Buy
25.31%
Upside
Reiterated
08/28/26
Agilent price target raised to $180 from $160 at Wells FargoAgilent price target raised to $180 from $160 at Wells Fargo
TD Cowen Analyst forecast on IT:1A
Daniel Brennan
TD Cowen
TD Cowen
€133.05→€154.5
Buy
25.31%
Upside
Assigned
08/27/26
Agilent Price Target Raised to $180 as Broad-Based Outperformance Drives Attractive Risk-Reward, Says Brennan
Piper Sandler Analyst forecast on IT:1A
David Westenberg
Piper Sandler
Piper Sandler
€128.75
Hold
4.42%
Upside
Reiterated
08/27/26
Piper Sandler Sticks to Its Hold Rating for Agilent (A)
Barclays Analyst forecast on IT:1A
Luke Sergott
Barclays
Barclays
€128.75→€150.21
Buy
21.83%
Upside
Reiterated
08/27/26
Agilent price target raised to $175 from $150 at BarclaysAgilent price target raised to $175 from $150 at Barclays
Bernstein Analyst forecast on IT:1A
Eve Burstein
Bernstein
Bernstein
€133.05→€154.5
Buy
25.31%
Upside
Reiterated
08/27/26
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), HOYA (HOCPF)
Stifel Nicolaus Analyst forecast on IT:1A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
€145.92→€154.5
Buy
25.31%
Upside
Reiterated
08/27/26
Stifel Nicolaus Remains a Buy on Agilent (A)
Bank of America Securities Analyst forecast on IT:1A
Michael Ryskin
Bank of America Securities
Bank of America Securities
€133.05→€154.5
Buy
25.31%
Upside
Reiterated
08/27/26
Agilent price target raised to $180 from $155 at BofAAgilent price target raised to $180 from $155 at BofA
Evercore ISI Analyst forecast on IT:1A
Vijay Kumar
Evercore ISI
Evercore ISI
€127.04→€147.64
Buy
19.74%
Upside
Reiterated
08/27/26
Agilent price target raised to $172 from $148 at Evercore ISIAgilent price target raised to $172 from $148 at Evercore ISI
J.P. Morgan Analyst forecast on IT:1A
Casey Woodring
J.P. Morgan
J.P. Morgan
€154.5→€163.09
Buy
32.27%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $180 at JPMorganAgilent price target raised to $190 from $180 at JPMorgan
Citi Analyst forecast on IT:1A
Patrick B Donnelly
Citi
Citi
€158.8→€163.09
Buy
32.27%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $185 at CitiAgilent price target raised to $190 from $185 at Citi
Goldman Sachs Analyst forecast on IT:1A
Evie Koslosky
Goldman Sachs
Goldman Sachs
€133.05→€150.21
Buy
21.83%
Upside
Assigned
08/27/26
Agilent price target raised to $175 from $155 at Goldman SachsAgilent price target raised to $175 from $155 at Goldman Sachs
RBC Capital Analyst forecast on IT:1A
Dan Leonard
RBC Capital
RBC Capital
€133.05→€158.8
Buy
28.79%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
Morgan Stanley Analyst forecast on IT:1A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€137.34→€150.21
Buy
21.83%
Upside
Assigned
08/13/26
Agilent (A) Receives a Buy from Morgan Stanley
Jefferies Analyst forecast on IT:1A
Tycho Peterson
Jefferies
Jefferies
€115.88
Hold
-6.02%
Downside
Initiated
07/09/26
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)
HSBC Analyst forecast on IT:1A
Sidharth Sahoo
HSBC
HSBC
€154.5→€141.63
Buy
14.87%
Upside
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on IT:1A
Evan Stampler
Wells Fargo
Wells Fargo
€137.34→€154.5
Buy
25.31%
Upside
Reiterated
08/28/26
Agilent price target raised to $180 from $160 at Wells FargoAgilent price target raised to $180 from $160 at Wells Fargo
TD Cowen Analyst forecast on IT:1A
Daniel Brennan
TD Cowen
TD Cowen
€133.05→€154.5
Buy
25.31%
Upside
Assigned
08/27/26
Agilent Price Target Raised to $180 as Broad-Based Outperformance Drives Attractive Risk-Reward, Says Brennan
Piper Sandler Analyst forecast on IT:1A
David Westenberg
Piper Sandler
Piper Sandler
€128.75
Hold
4.42%
Upside
Reiterated
08/27/26
Piper Sandler Sticks to Its Hold Rating for Agilent (A)
Barclays Analyst forecast on IT:1A
Luke Sergott
Barclays
Barclays
€128.75→€150.21
Buy
21.83%
Upside
Reiterated
08/27/26
Agilent price target raised to $175 from $150 at BarclaysAgilent price target raised to $175 from $150 at Barclays
Bernstein Analyst forecast on IT:1A
Eve Burstein
Bernstein
Bernstein
€133.05→€154.5
Buy
25.31%
Upside
Reiterated
08/27/26
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), HOYA (HOCPF)
Stifel Nicolaus Analyst forecast on IT:1A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
€145.92→€154.5
Buy
25.31%
Upside
Reiterated
08/27/26
Stifel Nicolaus Remains a Buy on Agilent (A)
Bank of America Securities Analyst forecast on IT:1A
Michael Ryskin
Bank of America Securities
Bank of America Securities
€133.05→€154.5
Buy
25.31%
Upside
Reiterated
08/27/26
Agilent price target raised to $180 from $155 at BofAAgilent price target raised to $180 from $155 at BofA
Evercore ISI Analyst forecast on IT:1A
Vijay Kumar
Evercore ISI
Evercore ISI
€127.04→€147.64
Buy
19.74%
Upside
Reiterated
08/27/26
Agilent price target raised to $172 from $148 at Evercore ISIAgilent price target raised to $172 from $148 at Evercore ISI
J.P. Morgan Analyst forecast on IT:1A
Casey Woodring
J.P. Morgan
J.P. Morgan
€154.5→€163.09
Buy
32.27%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $180 at JPMorganAgilent price target raised to $190 from $180 at JPMorgan
Citi Analyst forecast on IT:1A
Patrick B Donnelly
Citi
Citi
€158.8→€163.09
Buy
32.27%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $185 at CitiAgilent price target raised to $190 from $185 at Citi
Goldman Sachs Analyst forecast on IT:1A
Evie Koslosky
Goldman Sachs
Goldman Sachs
€133.05→€150.21
Buy
21.83%
Upside
Assigned
08/27/26
Agilent price target raised to $175 from $155 at Goldman SachsAgilent price target raised to $175 from $155 at Goldman Sachs
RBC Capital Analyst forecast on IT:1A
Dan Leonard
RBC Capital
RBC Capital
€133.05→€158.8
Buy
28.79%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
Morgan Stanley Analyst forecast on IT:1A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€137.34→€150.21
Buy
21.83%
Upside
Assigned
08/13/26
Agilent (A) Receives a Buy from Morgan Stanley
Jefferies Analyst forecast on IT:1A
Tycho Peterson
Jefferies
Jefferies
€115.88
Hold
-6.02%
Downside
Initiated
07/09/26
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)
HSBC Analyst forecast on IT:1A
Sidharth Sahoo
HSBC
HSBC
€154.5→€141.63
Buy
14.87%
Upside
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Agilent

3 Months
Dan LeonardRBC Capital
Success Rate
19/28 ratings generated profit
68%
Average Return
+5.11%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 67.86% of your transactions generating a profit, with an average return of +5.11% per trade.
1 Year
Dan LeonardRBC Capital
Success Rate
23/28 ratings generated profit
82%
Average Return
+23.11%
Copying Dan Leonard's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +23.11% per trade.
2 Years
Daniel AriasStifel Nicolaus
Success Rate
9/11 ratings generated profit
82%
Average Return
+15.02%
Copying Daniel Arias's trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +15.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1A Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
2
2
2
1
Buy
16
15
15
15
19
Hold
1
0
2
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
17
19
20
24
In the current month, 1A has received 20 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. 1A average Analyst price target in the past 3 months is 147.37.
Each month's total comprises the sum of three months' worth of ratings.

1A Financial Forecast

1A Earnings Forecast

Next quarter’s earnings estimate for 1A is €1.49 with a range of €1.48 to €1.52. The previous quarter’s EPS was €1.40. 1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1A is €1.49 with a range of €1.48 to €1.52. The previous quarter’s EPS was €1.40. 1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.

1A Sales Forecast

Next quarter’s sales forecast for 1A is €1.72B with a range of €1.71B to €1.72B. The previous quarter’s sales results were €1.62B. 1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.
Next quarter’s sales forecast for 1A is €1.72B with a range of €1.71B to €1.72B. The previous quarter’s sales results were €1.62B. 1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.

1A Stock Forecast FAQ

What is IT:1A’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilent’s 12-month average price target is 147.37.
    What is IT:1A’s upside potential, based on the analysts’ average price target?
    Agilent has 19.52% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Agilent a Buy, Sell or Hold?
          Agilent has a consensus rating of Strong Buy, which is based on 13 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Agilent’s share price target?
            The average share price target for Agilent is 147.37. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €163.09 ,and the lowest forecast is €115.88. The average share price target represents 19.52% Increase from the current price of €123.3.
              What do analysts say about Agilent?
              Agilent’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of Agilent?
                To buy shares of IT:1A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.